Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma

Published:2019-08-01 Issue:1 Volume:30 Page:186-194
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Rimola Jordi^ORCID,Forner Alejandro,Sapena Víctor,Llarch Neus,Darnell Anna,Díaz Alba,García-Criado Angeles,Bianchi Lluís,Vilana Ramon,Díaz-González Álvaro,Ayuso Carmen,Bruix Jordi,Reig María

Funder

Sociedad Española de Radiologia Medica

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-019-06351-0.pdf

Reference23 articles.

1. Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function. Ann Surg 235:373–382

2. Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S (2015) Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 261:947–955

3. Sala M, Llovet JM, Vilana R et al (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360

4. European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 69:182–236

5. Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key points for imaging diagnosis and response assessment for hepatocellular carcinoma in Latin America;Annals of Hepatology;2024-07

2. Local recurrence following a complete radiologic response in hepatocellular carcinoma patients: comparison of transarterial chemoembolisation and transarterial radioembolisation;Clinical Radiology;2024-05

3. Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives;Hepatobiliary Surgery and Nutrition;2024-02

4. Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis;Abdominal Radiology;2024-01-10

5. MRI apparent diffusion coefficient as potential biomarkers in the diagnosis of osteosarcoma;2023-11-21